GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BELLUS Health Inc (NAS:BLU) » Definitions » Financial Strength

BELLUS Health (BELLUS Health) Financial Strength : 7 (As of Mar. 2023)


View and export this data going back to 2000. Start your Free Trial

What is BELLUS Health Financial Strength?

BELLUS Health has the Financial Strength Rank of 7.

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors:

1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.
2. Debt to revenue ratio. The lower, the better.
3. Altman Z-Score.

BELLUS Health did not have earnings to cover the interest expense. BELLUS Health's debt to revenue ratio for the quarter that ended in Mar. 2023 was 99.92. As of today, BELLUS Health's Altman Z-Score is 103.21.


Competitive Comparison of BELLUS Health's Financial Strength

For the Biotechnology subindustry, BELLUS Health's Financial Strength, along with its competitors' market caps and Financial Strength data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BELLUS Health's Financial Strength Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BELLUS Health's Financial Strength distribution charts can be found below:

* The bar in red indicates where BELLUS Health's Financial Strength falls into.



BELLUS Health Financial Strength Calculation

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

BELLUS Health's Interest Expense for the months ended in Mar. 2023 was $-0.02 Mil. Its Operating Income for the months ended in Mar. 2023 was $-27.72 Mil. And its Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2023 was $0.83 Mil.

BELLUS Health's Interest Coverage for the quarter that ended in Mar. 2023 is

BELLUS Health did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

2. Debt to revenue ratio. The lower, the better.

BELLUS Health's Debt to Revenue Ratio for the quarter that ended in Mar. 2023 is

Debt to Revenue Ratio=Total Debt (Q: Mar. 2023 ) / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0.365 + 0.834) / 0.012
=99.92

3. Altman Z-Score.

Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

The zones of discrimination were as such:

When Z-Score is less than 1.81, it is in Distress Zones.
When Z-Score is greater than 2.99, it is in Safe Zones.
When Z-Score is between 1.81 and 2.99, it is in Grey Zones.

BELLUS Health has a Z-score of 103.21, indicating it is in Safe Zones. This implies the Z-Score is strong.

Good Sign:

Altman Z-score of 103.21 is strong.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BELLUS Health  (NAS:BLU) Financial Strength Explanation

The maximum rank is 10. Companies with rank 7 or higher will be unlikely to fall into distressed situations. Companies with rank of 3 or less are likely in financial distress.

BELLUS Health has the Financial Strength Rank of 7.


BELLUS Health Financial Strength Related Terms

Thank you for viewing the detailed overview of BELLUS Health's Financial Strength provided by GuruFocus.com. Please click on the following links to see related term pages.


BELLUS Health (BELLUS Health) Business Description

Traded in Other Exchanges
N/A
Address
275 Armand-Frappier Boulevard, Laval, QC, CAN, H7V 4A7
BELLUS Health Inc is a clinical-stage biopharmaceutical development company advancing novel therapeutics for conditions with a high unmet medical need, including BLU-5937, a P2X3 antagonist that has the potential to be a best-in-class therapeutic for chronic cough. The company operates in one business segment namely, the development of drug candidates for health solutions.

BELLUS Health (BELLUS Health) Headlines

From GuruFocus

BELLUS Health to Participate in Multiple Upcoming Investor Conferences

By Business Wire Business Wire 04-25-2022